The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination

Viral Infections, Non-HIV

Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration

Vaccine

Desai AP, Desai AP, Loomis GJ

doi: 10.1016/j.vaccine.2021.06.058

Viral Infections, Non-HIV

Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel

N Engl J Med

Pilishvili T, Gierke R, Fleming-Dutra KE, Farrar JL, Mohr NM, Talan DA, Krishnadasan A, Harland KK, Smithline HA, Hou PC, Lee LC, Lim SC, Moran GJ, Krebs E, Steele MT, Beiser DG, Faine B, Haran JP, Nandi U, Schrading WA, Chinnock B, Henning DJ, Lovecchio F, Lee J, Barter D, Brackney M, Fridkin SK, Marceaux-Galli K, Lim S, Phipps EC, Dumyati G, Pierce R, Markus TM, Anderson DJ, Debes AK, Lin MY, Mayer J, Kwon JH, Safdar N, Fischer M, Singleton R, Chea N, Magill SS, Verani JR, Schrag SJ, Vaccine Effectiveness among Healthcare Personnel Study Team.

doi: 10.1056/NEJMoa2106599

Viral Infections, Non-HIV

Ensuring global access to COVID-19 vaccines

Lancet.

Yamey G, Schäferhoff M, Hatchett R, Pate M, Zhao F, McDade KK

doi: 10.1016/S0140-6736(20)30763-7.

Viral Infections, Non-HIV

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Lancet

Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, Brooks N, Smaja M, Mircus G, Pan K, Southern J, Swerdlow DL, Jodar L, Levy Y, Alroy-Preis S

doi: 10.1016/S0140-6736(21)00947-8

Further Publications Infectiology

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully-vaccinated hospitalized COVID-19 patients in Israel

Clin Microbiol Infect

Brosh-Nissimov T, Orenbuch-Harroch E, Chowers M, Elbaz M, Nesher L, Stein M, Maor Y, Cohen R, Hussein K, Weinberger M, Zimhony O, Chazan B, Najjar R, Zayyad H, Rahav G, Wiener-Well Y

doi: 10.1016/j.cmi.2021.06.036

Viral Infections, Non-HIV

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

N Engl J Med

Thompson MG, Burgess JL, Naleway AL, Tyner H, Yoon SK, Meece J, Olsho LEW, Caban-Martinez AJ, Fowlkes AL, Lutrick K, Groom HC, Dunnigan K, Odean MJ, Hegmann K, Stefanski E, Edwards LJ, Schaefer-Solle N, Grant L, Ellingson K, Kuntz JL, Zunie T, Thiese MS, Ivacic L, Wesley MG, Mayo Lamberte J, Sun X, Smith ME, Phillips AL, Groover KD, Yoo YM, Gerald J, Brown RT, Herring MK, Joseph G, Beitel S, Morrill TC, Mak J, Rivers P, Poe BP, Lynch B, Zhou Y, Zhang J, Kelleher A, Li Y, Dickerson M, Hanson E, Guenther K, Tong S, Bateman A, Reisdorf E, Barnes J, Azziz-Baumgartner E, Hunt DR, Arvay ML, Kutty P, Fry AM, Gaglani M

doi: 10.1056/NEJMoa2107058

Viral Infections, Non-HIV

Vaccine designers take first shots at COVID-19

Science.

Cohen J

doi: 10.1126/science.368.6486.14.

Viral Infections, Non-HIV

A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China

Clin Infect Dis.

Gong J, Ou J, Qiu X, Jie Y, Chen Y, Yuan L, Cao J, Tan M, Xu W, Zheng F, Shi Y, Hu B

doi: 10.1093/cid/ciaa443.

Viral Infections, Non-HIV

Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19

JAMA Intern Med.

Liang W, Liang H, Ou L, Chen B, Chen A, Li C, Li Y, Guan W, Sang L, Lu J, Xu Y, Chen G, Guo H, Guo J, Chen Z, Zhao Y, Li S, Zhang N, Zhong N, He J, China Medical Treatment Expert Group for COVID-19.

doi: 10.1001/jamainternmed.2020.2033.

Related content

Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration

Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel

Ensuring global access to COVID-19 vaccines

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully-vaccinated hospitalized COVID-19 patients in Israel

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Vaccine designers take first shots at COVID-19

A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China

Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19